Cited by 97

The DOI matches its Crossref record; 1 of the 1 references it cites were found in a registry or an index.

Matrix metalloproteinase (MMP) system in brain: identification and characterization of brain-specific MMP highly expressed in cerebellum.

Sekine‐Aizawa, Yoko, Hama, Emi, Watanabe, Kaori, Tsubuki, Satoshi, Kanai‐Azuma, Masami, Kanai, Yoshiakira, Arai, Hiroyuki, Aizawa, Hiroyuki, Iwata, Nobuhisa, Saido, Takaomi C.·2001·European Journal of Neuroscience

Abstract

The matrix metalloproteinase (MMP) family, comprising more than 20 isoforms, modulates the extracellular milieu by degrading extracellular matrix (ECM) proteins. Because MMP is one of the few groups of proteinases capable of hydrolysing insoluble fibrillar proteins, they are likely to play crucial roles in regulating both normal and pathophysiological processes in the brain. However, little is yet known about their possible neuronal functions due presumably to their unusual redundancy and to the absence of a complete catalogue of isoforms. As an initial step in understanding the MMP system in the brain, we analysed an expression spectrum of MMP in rat brain using RT‐PCR and discovered a novel brain‐specific MMP, MT5‐MMP. MT5‐MMP was the predominant species among the nongelatinase‐type isoforms in brain. MT5‐MMP, present in all brain tissues examined, was most strongly expressed in cerebellum and was localized in the membranous structures of expressing neurons, as assessed biochemically and immunohistochemically. In cerebellum, its expression was regulated developmentally and was closely associated with dendritic tree formation of Purkinje cells, suggesting that MT5‐MMP may contribute to neuronal development. Furthermore, its stable postdevelopmental expression and colocalization with senile plaques in Alzheimer brain indicates possible roles in neuronal remodeling naturally occurring in adulthood and in regulating pathophysiological processes associated with advanced age.

Overview

Integrity signals

Registry

Crossref · 10.1046/j.0953-816x.2001.01462.x

Cites

1 of 1 references verified0 citation errors · 0 not checkable

Statistics

Recomputing p-values needs the paper’s full text.

Verification

Claims the paper makes

This paper’s full text isn’t openly available, so its claims and self-check weren’t run. The registry and citation checks still apply.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Citations

Cites

Flagged first, then by citations

Research works printed but not linked: 36

  1. 10.1083/jcb.119.5.1287 · DOI
  2. 10.1073/pnas.93.6.2448 · DOI
  3. 10.1002/cne.901450305 · DOI
  4. 10.1002/cne.901450402 · DOI · Paper page
  5. 10.1074/jbc.273.36.23004 · DOI
  6. 10.1016/s0166-2236(96)01030-2 · DOI · Paper page
  7. Iwata N., 2000, Identification of the major Aβ1−42‐degrading catabolic pathway in brain parenchyma: Suppression leads to biochemical and pathological deposition, Nature Med., 6, 143, 10.1038/72237 · DOI · Paper page
  8. 10.1016/S0006-8993(00)02035-7 · DOI
  9. Joachim C.L., 1989, Diffuse senile plaques occur commonly in the cerebellum in Alzheimer's disease, Am. J. Pathol., 135, 309
  10. 10.1016/S1367-5931(98)80122-1 · DOI
  11. 10.1083/jcb.133.3.667 · DOI
  12. Llano E., 1999, Identification and characterization of human MT5‐MMP, a new membrane‐bound activator of progelatinase A overexpressed in brain tumors, Cancer Res., 59, 2570
  13. 10.1038/362839a0 · DOI
  14. 10.1016/s0955-0674(99)00022-8 · DOI
  15. Murphy G., 1993, Proteolysis and Protein Turnover., 25
  16. Nagase H., 1997, Activation mechanisms of matrix metalloproteinases, Biol. Chem., 378, 151
  17. 10.1006/jmbi.1999.3492 · DOI
  18. 10.1074/jbc.274.13.8925 · DOI
  19. 10.1002/cne.901410303 · DOI
  20. Saido T.C., 2000, Degradation of amyloid‐β peptide: a key to Alzheimer pathogeneis, prevention, and therapy, Neurosci. News, 5, 52
  21. Saido T.C., 2000, Neuroscientific Basis of Dementia.
  22. 10.1016/0896-6273(95)90301-1 · DOI · Paper page
  23. 10.1093/oxfordjournals.jbchem.a123723 · DOI
  24. 10.1146/annurev.cb.04.110188.000521 · DOI
  25. Sambrook J., 1989, A Laboratory Manual.
  26. 10.1083/jcb.127.1.187 · DOI
  27. 10.1016/s0962-8924(98)01363-4 · DOI · Paper page
  28. 10.1073/pnas.76.9.4350 · DOI
  29. 10.1523/JNEUROSCI.20-11-03937.2000 · DOI
  30. 10.1523/JNEUROSCI.19-12-04994.1999 · DOI
  31. 10.1523/JNEUROSCI.20-05-01657.2000 · DOI
  32. 10.1016/S0092-8674(00)80429-8 · DOI
  33. 10.1007/s004010050350 · DOI
  34. Yamaguchi H., 1989, Electron micrograph of diffuse plaques: Initial stage of senile plaque formation in the Alzheimer brain, Am. J. Pathol., 135, 593
  35. 10.1016/s0166-2236(97)01169-7 · DOI
  36. 10.1007/s004010050904 · DOI

Cited by

Sorted by citations

Metadata

Authors
Sekine‐Aizawa, Y., Hama, E., Watanabe, K., Tsubuki, S., Kanai‐Azuma, M., Kanai, Y., Arai, H., Aizawa, H., Iwata, N., & Saido, T. C.
Venue
European Journal of Neuroscience
Publisher
Wiley
Published
2001-03
Volume
13
Issue
5
Pages
935-948
ISSN
  • 0953-816X
  • 1460-9568
Cited by
97
References
1
Language
en

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review